文献速递精神分裂症与精神病性障碍

精神分裂症患者脑铁降低与纹状体多巴胺功能亢进:QSM MRI与PET研究

Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study.
PubMed 文献 · Am J Psychiatry · 2025-01-01

该病例对照研究采用定量磁化率成像(QSM)MRI测量159名参与者(80名对照、79名早期精神分裂症患者)的黑质-腹侧被盖区(SN-VTA)磁化率,发现患者SN-VTA磁化率显著低于对照(d=-0.66,95% CI=-0.98,-0.34),且SN-VTA磁化率与纹状体多巴胺合成能力(Ki cer)呈显著负相关(r=-0.44)。结果表明SN-VTA非神经黑色素结合铁降低可能促进精神分裂症纹状体多巴胺功能亢进。

要点

  • 精神分裂症患者SN-VTA磁化率较对照降低,效应量d=-0.66。
  • SN-VTA磁化率与纹状体Ki cer负相关(r=-0.44),独立于髓鞘和神经黑色素指标。
  • 腹侧SN-VTA效应最强,提示局部铁缺乏与多巴胺亢进相关。

核心结论

  • SN-VTA非神经黑色素结合铁降低可能促进精神分裂症纹状体多巴胺功能亢进。

研究设计与样本

  • 病例对照研究,159名参与者(对照80名,早期精神分裂症79名,含未用药或停药患者)。
  • 采用QSM MRI测量SN-VTA磁化率,并在99名参与者中辅以NM-MRI和DTI。
  • 对40名精神分裂症患者行[18F]-DOPA PET评估纹状体多巴胺合成能力(Ki cer)。

主要发现

  • 患者SN-VTA磁化率低于对照(d=-0.66,95% CI=-0.98,-0.34)。
  • 控制平均弥散率和NM-MRI对比噪声比后,组间差异仍显著。
  • SN-VTA磁化率与纹状体Ki cer显著负相关(r=-0.44),独立于平均弥散率和NM-MRI对比噪声比。
  • 上述分析中腹侧SN-VTA效应最强。

临床怎么用

  • QSM测量的SN-VTA低磁化率可作为精神分裂症多巴胺功能亢进的潜在影像标志物。
  • 低铁可能成为精神分裂症治疗靶点,但需进一步研究验证。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Neuroimaging studies have independently associated schizophrenia with low iron and elevated dopamine synthesis. While preclinical research demonstrates that midbrain iron deficiency leads to striatal hyperdopaminergia, this relationship has not been studied in schizophrenia. The authors conducted a case-control study to examine differences in tissue magnetic susceptibility, a marker of brain iron, and correlated these with striatal dopamine synthesis capacity. METHODS: Magnetic susceptibility in the substantia nigra and ventral tegmental area (SN-VTA) was measured using quantitative susceptibility mapping (QSM) MRI in 159 participants (control subjects, N=80; early-course schizophrenia, N=79, including patients who were antipsychotic-naïve or antipsychotic-free). Because magnetic susceptibility is increased by neuromelanin and reduced by myelin, neuromelanin-sensitive MRI (NM-MRI) and diffusion tensor imaging (DTI) were employed to investigate the influence of neuromelanin and myelin on the QSM findings in 99 participants (control subjects, N=38; schizophrenia patients, N=61). Dopamine synthesis capacity (Ki cer) was then assessed with [18F]-DOPA positron emission tomography in 40 people from the schizophrenia group to test whether low SN-VTA magnetic susceptibility was related to high striatal Ki cer. RESULTS: SN-VTA magnetic susceptibility was lower in patients with schizophrenia than in control subjects (d=-0.66, 95% CI=-0.98, -0.34). This difference remained significant in analyses controlling for mean diffusivity (a DTI measure inversely correlating with myelin concentration) and NM-MRI contrast-to-noise ratios. SN-VTA magnetic susceptibility was significantly inversely correlated with striatal Ki cer, independent of mean diffusivity and NM-MRI contrast-to-noise ratios (r=-0.44). In both analyses, the strongest effects were observed in the ventral SN-VTA. CONCLUSIONS: These findings suggest that lower levels of non-neuromelanin-bound iron in the SN-VTA contribute to striatal hyperdopaminergia in schizophrenia. Further investigation is warranted to understand the role of low iron in schizophrenia and its potential as a treatment target.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Vano LJ, McCutcheon RA, Sedlacik J, et al. Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study. Am J Psychiatry. 2025. PMID: 40887951. doi:10.1176/appi.ajp.20240512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。